Immunotherapy in myasthenia gravis in the era of biologics
Year: 2018
Type: review
Source: Nature Reviews Neurology
Author: Marinos C. Dalakas
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: myasthenia gravis, immunotherapy, biologics, eculizumab, rituximab, anti-CD20 monoclonal antibody, belimumab, efgartigimod, complement C5, B-cell depletion, BAFF, anti-cytokine therapy, immune checkpoint inhibitors, steroid-sparing therapy, refractory myasthenia gravis, treatment algorithm
Open Access status: closed
OpenAlex ID: W2904124424
